ReviewImmunity & ageing : I & A2021

An evaluation of the recognised systemic inflammatory biomarkers of chronic sub-optimal inflammation provides evidence for inflammageing (IFA) during multiple sclerosis (MS).

Christopher BoltonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.